Literature DB >> 24606219

HIV-1 Rev multimerization: mechanism and insights.

Thomas Vercruysse, Dirk Daelemans1.   

Abstract

To export intron-containing viral mRNAs that encode the structural components of new viral particles from the nucleus to the cytoplasm, HIV-1 uses the cellular CRM1 export pathway that is exploited by the viral Rev protein. Rev multimerizes on the Rev response element (RRE) present in the intron-containing RNA species to bridge these to the cellular export factor CRM1. As a result, this Rev-RRE complex is exported to the cytoplasm. This review provides a systematic overview of different aspects of the crucial function of Rev multimerization, such as co-operative Rev-Rev and Rev-RNA interactions, the biological function of Rev multimerization, the relevance of Rev multimerization in the absence of RRE and its potential as a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24606219     DOI: 10.2174/1570162x12666140307094603

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  10 in total

1.  Nuclear Export Signal Masking Regulates HIV-1 Rev Trafficking and Viral RNA Nuclear Export.

Authors:  Ryan T Behrens; Mounavya Aligeti; Ginger M Pocock; Christina A Higgins; Nathan M Sherer
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

2.  Cooperativity among Rev-associated nuclear export signals regulates HIV-1 gene expression and is a determinant of virus species tropism.

Authors:  Mounavya Aligeti; Ryan T Behrens; Ginger M Pocock; Johannes Schindelin; Christian Dietz; Kevin W Eliceiri; Chad M Swanson; Michael H Malim; Paul Ahlquist; Nathan M Sherer
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 3.  HIV Rev Assembly on the Rev Response Element (RRE): A Structural Perspective.

Authors:  Jason W Rausch; Stuart F J Le Grice
Journal:  Viruses       Date:  2015-06-12       Impact factor: 5.048

4.  Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.

Authors:  Noëlie Campos; Renier Myburgh; Aude Garcel; Audrey Vautrin; Laure Lapasset; Erika Schläpfer Nadal; Florence Mahuteau-Betzer; Romain Najman; Pauline Fornarelli; Katjana Tantale; Eugénia Basyuk; Martial Séveno; Julian P Venables; Bernard Pau; Edouard Bertrand; Mark A Wainberg; Roberto F Speck; Didier Scherrer; Jamal Tazi
Journal:  Retrovirology       Date:  2015-04-09       Impact factor: 4.602

5.  Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding.

Authors:  Chijioke N Umunnakwe; Hyelee Loyd; Kinsey Cornick; Jerald R Chavez; Drena Dobbs; Susan Carpenter
Journal:  Retrovirology       Date:  2014-12-23       Impact factor: 4.602

6.  Diverse activities of viral cis-acting RNA regulatory elements revealed using multicolor, long-term, single-cell imaging.

Authors:  Ginger M Pocock; Laraine L Zimdars; Ming Yuan; Kevin W Eliceiri; Paul Ahlquist; Nathan M Sherer
Journal:  Mol Biol Cell       Date:  2016-11-30       Impact factor: 4.138

7.  Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing.

Authors:  Audrey Vautrin; Laurent Manchon; Aude Garcel; Noëlie Campos; Laure Lapasset; Abdelhamid Mahdi Laaref; Roman Bruno; Marie Gislard; Emeric Dubois; Didier Scherrer; J Hartmut Ehrlich; Jamal Tazi
Journal:  Sci Rep       Date:  2019-01-28       Impact factor: 4.379

8.  Modification of Nuclear Compartments and the 3D Genome in the Course of a Viral Infection.

Authors:  S V Razin; A A Gavrilov; O V Iarovaia
Journal:  Acta Naturae       Date:  2020 Oct-Dec       Impact factor: 1.845

9.  Binding stoichiometry and structural model of the HIV-1 Rev/importin β complex.

Authors:  Didier Spittler; Rose-Laure Indorato; Elisabetta Boeri Erba; Elise Delaforge; Luca Signor; Simon J Harris; Isabel Garcia-Saez; Andrés Palencia; Frank Gabel; Martin Blackledge; Marjolaine Noirclerc-Savoye; Carlo Petosa
Journal:  Life Sci Alliance       Date:  2022-08-22

10.  Differential interaction between human and murine Crm1 and lentiviral Rev proteins.

Authors:  Yan Yue; Ayse K Coskun; Navneet Jawanda; Jim Auer; Richard E Sutton
Journal:  Virology       Date:  2017-10-10       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.